Published in QJM on May 15, 2007
Insulin Degludec Titration Using Mobile Insulin Dosing System | NCT03091712
The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care (2012) 2.33
Adherence to therapies in patients with type 2 diabetes. Diabetes Ther (2013) 2.23
Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. J Family Community Med (2012) 1.37
Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c). Diabet Med (2010) 1.35
Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes. Diabet Med (2013) 1.32
The Diabetes Self-Management Questionnaire (DSMQ): development and evaluation of an instrument to assess diabetes self-care activities associated with glycaemic control. Health Qual Life Outcomes (2013) 1.06
Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus. Adv Ther (2014) 1.01
Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs: when and for whom? Diabetes Care (2013) 0.97
A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes Obes Metab (2013) 0.95
Quality of care associated with common chronic diseases in a 9-state Medicaid population utilizing claims data: an evaluation of medication and health care use and costs. Popul Health Manag (2010) 0.94
Non-adherence in type 2 diabetes: practical considerations for interpreting the literature. Patient Prefer Adherence (2013) 0.94
Insulin degludec: pharmacokinetic properties in subjects with hepatic impairment. Clin Drug Investig (2014) 0.93
Insulin use, prescription patterns, regimens and costs.-a narrative from a developing country. Diabetol Metab Syndr (2012) 0.93
Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes. Pharm World Sci (2009) 0.92
Barriers to achieving glycemic targets: who omits insulin and why? Diabetes Care (2010) 0.91
Performance of an Electronic Diary System for Intensive Insulin Management in Global Diabetes Clinical Trials. Diabetes Technol Ther (2015) 0.89
Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals. Patient Prefer Adherence (2013) 0.83
Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetes. Diabetes Care (2013) 0.82
Effect of pharmaceutical care on medication adherence of patients newly prescribed insulin therapy: a randomized controlled study. Patient Prefer Adherence (2015) 0.80
Adherence to treatment guidelines and therapeutic regimens: a US claims-based benchmark of a commercial population. Popul Health Manag (2010) 0.79
Efficacy and safety of once-daily insulin degludec dosed flexibly at convenient times vs fixed dosing at the same time each day in a Japanese cohort with type 2 diabetes: A randomized, 26-week, treat-to-target trial. J Diabetes Investig (2016) 0.77
Evolving trends in insulin delivery in pursuit of improvements in diabetes management. Am Health Drug Benefits (2010) 0.77
Efficacy and safety of ultra-long-acting insulin degludec. Ther Adv Endocrinol Metab (2012) 0.77
Comparison of adherence and persistence among adults with type 2 diabetes mellitus initiating saxagliptin or linagliptin. Patient Prefer Adherence (2016) 0.75
Combination therapy in type 2 diabetes mellitus: adding empagliflozin to basal insulin. Drugs Context (2015) 0.75
Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database study. BMJ Open Diabetes Res Care (2016) 0.75
Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin. Diabetes Ther (2016) 0.75
ADHERENCE AND QUALITY OF LIFE IN PATIENTS WITH TYPE II DIABETES MELLITUS IN NORTHERN GREECE. Mater Sociomed (2016) 0.75
Painful and Prolonged Muscle Cramps following Insulin Injections in a Patient with Type 2 Diabetes Mellitus: Revisiting the 1992 Duke Case. Front Endocrinol (Lausanne) (2017) 0.75
The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study. Pharm Pract (Granada) (2017) 0.75
Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional Analysis. Diabetes Ther (2017) 0.75
Association of road-traffic accidents with benzodiazepine use. Lancet (1998) 4.01
Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia (2006) 3.94
Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med (2002) 3.90
Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med (2008) 2.85
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med (2005) 2.78
Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol (2000) 2.71
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension (2000) 2.55
Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus. Diabet Med (2000) 2.50
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia (2013) 2.31
The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia (2010) 2.26
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study. Clin Pharmacol Ther (2010) 2.22
Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ (1999) 2.14
Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia (2011) 2.12
Glaucoma incidence in an unselected cohort of diabetic patients: is diabetes mellitus a risk factor for glaucoma? DARTS/MEMO collaboration. Diabetes Audit and Research in Tayside Study. Medicines Monitoring Unit. Br J Ophthalmol (2000) 1.85
Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology. Diabet Med (2005) 1.75
DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension (1999) 1.71
Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines. Diabet Med (2001) 1.71
A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer (2009) 1.56
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer (2005) 1.52
Should diabetic patients be screened for glaucoma? DARTS/MEMO Collaboration. Br J Ophthalmol (1999) 1.49
ABC of arterial and venous disease: vascular complications of diabetes. BMJ (2000) 1.49
Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 2001-2006. Diabet Med (2008) 1.37
Extensive bilateral leg ulceration. Clin Exp Dermatol (2012) 1.37
Technical report: quantitative assessment of diaphragmatic movement--a reproducible method using ultrasound. Clin Radiol (1992) 1.30
Which drugs benefit diabetic patients for secondary prevention of myocardial infarction? DARTS/MEMO Collaboration. Diabet Med (1998) 1.29
The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes. Diabet Med (2006) 1.26
Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Diabetologia (2008) 1.23
A national retinal screening programme for diabetes in Scotland. Diabet Med (2003) 1.22
Is there equity of service delivery and intermediate outcomes in South Asians with type 2 diabetes? Analysis of DARTS database and summary of UK publications. J Public Health (Oxf) (2009) 1.22
TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia (2007) 1.21
Prevalence and aetiology of hypothyroidism in the young. Arch Dis Child (2000) 1.21
How reproducible is bilateral forearm plethysmography? Br J Clin Pharmacol (1998) 1.21
Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. Diabetes Care (2000) 1.20
Prevalence and outcomes of use of potentially inappropriate medicines in older people: cohort study stratified by residence in nursing home or in the community. BMJ Qual Saf (2011) 1.20
A randomized control trial of the effect of negotiated telephone support on glycaemic control in young people with Type 1 diabetes. Diabet Med (2002) 1.18
Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab (2006) 1.18
Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin Endocrinol (Oxf) (2007) 1.14
Dietary sodium restriction impairs insulin sensitivity in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1998) 1.14
Stratification of foot ulcer risk in patients with diabetes: a population-based study. Int J Clin Pract (2006) 1.13
A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland. Diabet Med (2010) 1.13
Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia (2006) 1.12
Long-term adherence to statin treatment in diabetes. Diabet Med (2008) 1.12
Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia (2012) 1.11
Cyclophosphamide protection in NZB/NZW disease. Mechanisms and therapeutic regimens. Arthritis Rheum (1976) 1.11
Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality? Diabetologia (2007) 1.11
Blindness in patients with diabetes who have been screened for eye disease. Eye (Lond) (1999) 1.10
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs. Diabetologia (2012) 1.08
Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles. Diabetologia (2008) 1.05
Mortality of South Asian patients with insulin-treated diabetes mellitus in the United Kingdom: a cohort study. Diabet Med (2004) 1.04
Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes. Diabet Med (2002) 1.04
Changes in treatment after the start of oral hypoglycaemic therapy in Type 2 diabetes: a population-based study. Diabet Med (2002) 1.03
The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. J Clin Endocrinol Metab (2004) 1.03
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study. Clin Pharmacol Ther (2009) 1.02
The influence of field size on the late tolerance of the rat spinal cord to single doses of X rays. Br J Radiol (1987) 0.99
Diagnosis of type 2 diabetes at an older age: effect on mortality in men and women. Diabetes Care (2004) 0.98
A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain. Eur J Pain (2015) 0.97
The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia (2005) 0.96
Epidemiology and economic burden of viral hepatitis: an observational population based study. Gut (2002) 0.96
Which people with Type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK region. Diabet Med (2009) 0.96
Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study. Diabetes Obes Metab (2009) 0.96
Some principles and practices of genetic biobanking studies. Eur Respir J (2009) 0.95
Reporting of diabetes on death certificates of 1872 people with type 2 diabetes in Tayside, Scotland. Eur J Public Health (2007) 0.94
A role for coding functional variants in HNF4A in type 2 diabetes susceptibility. Diabetologia (2010) 0.93
The annual incidence of diabetic complications in a population of patients with Type 1 and Type 2 diabetes. Diabet Med (2005) 0.91
Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland. Diabetologia (2012) 0.91
Heritability of chronic pain in 2195 extended families. Eur J Pain (2012) 0.90
Exaggerated vasopressin secretion and attenuated osmoregulated thirst in human survivors of hyperosmolar coma. Diabetologia (1999) 0.89
Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study. Diabet Med (2002) 0.88
Pathogenic role of a monoclonal IgA (kappa ) anti-IgG paraprotein associated with hemorrhagic diathesis, rheumatoid arthritis, vascular purpura, and acute membranoproliferative glomerulonephritis. J Clin Immunol (1982) 0.87
Extractable nuclear antigen effect on the DNA anti-DNA reaction and NZB/NZW mouse nephritis. J Clin Invest (1975) 0.87
The clinical implications of diabetic heart disease. Eur Heart J (1998) 0.87
Cigarette smoking in men and vascular responsiveness. Br J Clin Pharmacol (2001) 0.86
Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia (2011) 0.85
Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment. Scand J Gastroenterol Suppl (1981) 0.85
Investigation of known estimated glomerular filtration rate loci in patients with type 2 diabetes. Diabet Med (2013) 0.84
X-ray diagnosis of acute scaphoid fractures. J Hand Surg Br (2005) 0.83
The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia (2012) 0.83
Does direct ophthalmoscopy improve retinal screening for diabetic eye disease by retinal photography? Diabet Med (2002) 0.83
Fear of visual loss in patients with diabetes: results of the prevalence of diabetic eye disease in Tayside, Scotland (P-DETS) study. Diabet Med (2007) 0.82
Renal resistance to vasopressin in poorly controlled type 1 diabetes mellitus. Am J Physiol Endocrinol Metab (2000) 0.82
FIRI: a fair insulin resistance index? Lancet (1996) 0.82
Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study. Diabetes Care (2000) 0.82
Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis. Br J Dermatol (1999) 0.81
Lisinopril improves endothelial function in chronic cigarette smokers. Clin Sci (Lond) (2001) 0.81
A comparison of the effects of methotrexate and misonidazole on the germinal cells of the subependymal plate of the rat. Br J Radiol (1995) 0.80
Birthweight and other pregnancy outcomes in a cohort of women with pre-gestational insulin-treated diabetes mellitus, Scotland, 1979-95. Diabet Med (2005) 0.80
Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin Sci (Lond) (1997) 0.79
Does an automated thyroid register improve the clinical management of hypothyroid patients? An observational study. Clin Endocrinol (Oxf) (2005) 0.79
Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial. J Clin Endocrinol Metab (2000) 0.79
Ultrasonic evaluation of movement of the diaphragm after acute cerebral infarction. J Neurol Neurosurg Psychiatry (1995) 0.79
No association between non-steroidal anti-inflammatory drugs and acute appendicitis in a case-control study. Br J Surg (1997) 0.78
Potential confounding effect of hand-warming on the measurement of insulin sensitivity. Clin Sci (Lond) (1996) 0.78
Modulation of the activity and assessment of the receptor selectivity in a series of new RGD-containing peptides. Int J Pept Protein Res (1993) 0.78
The disposition of carboplatin in ovarian cancer patients. Cancer Chemother Pharmacol (1988) 0.78
Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus. Diabetologia (2007) 0.78